1)
Jain R, Mallya M v, Amoncar S, et al. Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India. Transfusion Clinique et Biologique. Published online 2021. doi:10.1016/J.TRACLI.2021.07.004
2)
Wajnberg A, Amanat F, Firpo A, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370(6521):1227-1230. doi:10.1126/ SCIENCE.ABD7728/SUPPL_ FILE/PAP.PDF
3)
Gudbjartsson DF, Norddahl GL, Melsted P, et al. Humoral Immune Response to SARS-CoV-2 in Iceland. New England Journal of Medicine. 2020;383(18):1724-1734. doi:10.1056/NEJMOA2026116/ SUPPL_ FILE/NEJMOA2026116_ DISCLOSURES.PDF
4)
Braun J, Loyal L, Frentsch M, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 2020 587:7833. 2020;587(7833):270-274. doi:10.1038/s41586-020-2598-9
5)
Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181(7):1489–1501.e15. doi:1 0.1016/J.CELL.2020.05.015
6)
le Bert N, Clapham HE, Tan AT, et al. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. The Journal of experimental medicine. 2021;218(5). doi:10.1084/JEM.20202617
7)
Shomuradova AS, Vagida MS, Sheetikov SA, et al. SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors. Immunity. Published online November 2020. doi:10.1016/j.immuni. 2020.11.004
8)
Weiskopf D, Schmitz KS, Raadsen MP, et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Science immunology. 2020;5(48). doi:10.1126/SCIIMMUNOL.ABD2071
9)
Anderson EJ, Rouphael NG, Widge AT, et al. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. New England Journal of Medicine. 2020;383(25):2427-2438. doi:10.1056/NEJMOA2028436/ SUPPL_FILE/NEJMOA2028436_DATA - SHARING.PDF
10)
Aleksei Titov, Regina Shaykhutdinova, Anton V. Ersov, et al. Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2, 2021.